MNKD Stock Analysis: Buy, Sell, or Hold?
MNKD - Mannkind Corporation
$4.52
0.47 (11.60%)
▲
5d:
+15.01%
30d:
+31.78%
90d:
+77.95%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Smart Money Accumulation
None View Scanner →
Strength: 5.3/10
Get Alerted When MNKD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: MNKD is 10.8% above its trading range ($4.08). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: MNKD is 10.8% above its trading range ($4.08). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: MNKD is currently trading at $4.52, which is considered extended relative to its 30-day fair value range of $3.50 to $4.08. The stock's valuation (Forward PE: 23.5) is in line with its historical norms (24.5). Remarkably, the market is currently pricing in an annual earnings decline of 1.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, MNKD is showing sideways momentum. The price is approaching resistance at $4.54. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 11.6% recently.
Market Sentiment: MNKD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.59 (+68.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MNKD is showing sideways momentum. The price is approaching resistance at $4.54. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 11.6% recently.
Market Sentiment: MNKD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.59 (+68.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.50 -
$4.08
Company Quality Score
66/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
MNKD is technically overbought (RSI 70). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+10.8% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+11.6%)
- BULLISH: Trading 68.0% below Wall St target ($7.59)
Trading Range Analysis
30-Day Trading Range
$3.50 -
$4.08
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.77
Resistance Level
$4.55
Current Trend
Sideways
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.48
Wall Street Target
$7.59
(+68.0%)
Revenue Growth (YoY)
15.1%
Earnings Growth (YoY)
-34.9%
Profit Margin
-6.6%
Valuation Discount vs History
-1.4% cheaper
PE vs Historical
23.5 vs 24.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.4%
(market-implied from PE analysis)
1-Year Target
$4.46
(-1%)
2-Year Target
$4.39
(-3%)
3-Year Target
$4.33
(-4%)
3-Yr Target (if PE normalizes)
(PE: 23→25)
$4.52
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.5, Growth: 126.5%)
$15.25
(+238%)
Base:
(SPY PE: 21.8, Growth: 126.5%)
$14.15
(+213%)
Bear:
(PE: 18.5, Growth: 126.5%)
$12.03
(+166%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 23.5 to 24.5
Stabilization Target:
$4.72
(+4.3%)
PE Expansion Potential:
+4.3%
Share & Embed Analysis
Last updated: July 02, 2026 9:40 PM ET
Data refreshes hourly during market hours. Next update: 10:40 PM
Data refreshes hourly during market hours. Next update: 10:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MNKD showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Michael Castagna
BUY
100000 shares
2026-03-10
Stuart A Tross
SELL
47006 shares
2026-01-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 55 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 63 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 63 BUY |
Advanced MNKD Option Strategies
Professional options setups generated by AI based on today's MNKD price and gamma walls.
